bring this information to you.
With that, I'll ask Nakissa to come and share with you what's the Rapid Response Team and what is it doing.
DR. SADRIEH: Hi. I'm going to talk about the Rapid Response Team. This is the last presentation of this advisory committee meeting, and I promise it's going to be a short one. Thank you.
I'll give you an overview of the Rapid Response Team. It's a research-based mechanism that helps provide research support to the review divisions and ultimately the drug approval process. It also helps to respond to literature reports of drug inefficacy or toxicity. The Rapid Response Team is also used to evaluate suspected causes of therapeutic inequivalence. By this, I don't mean that we go and sort of do detective work to find out what's the cause, but when a cause is identified and research needs to be done, then the Rapid Response Team sort of mobilizes the laboratory resources to try and address the research needs to come up with an answer for what's been identified. Also, we've provided some data for counter-terrorism initiatives, and I'll be